—

AstraZeneca PLC (AZN.L) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 55 out of 100 (momentum 60 · quality 75 · valuation 44), as of 2026-11-11.
  • Signal: Recovery attempt under the 200-day — Trades +10.6% vs the 50-day and +3.9% vs the 200-day average, 10.2% below the 52-week high and +41.3% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: AstraZeneca PLC trades 10.6% above its 50-day and 3.9% above its 200-day moving average. (as of 2026-11-10)

AstraZeneca discovers, develops, manufactures and sells prescription medicines across oncology, cardiovascular and renal disease, respiratory and immunology, vaccines, and rare diseases. It sells through distributors and local offices across the UK, the Americas, Europe, Asia, Africa and Australasia.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the AZN.L overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +10.6% vs the 50-day and +3.9% vs the 200-day average, 10.2% below the 52-week high and +41.3% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on AZN.L?

Recovery attempt under the 200-day — Trades +10.6% vs the 50-day and +3.9% vs the 200-day average, 10.2% below the 52-week high and +41.3% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AZN.L above its 50-day and 200-day moving averages?

As of 2026-11-10, AstraZeneca PLC trades +10.6% above its 50-day and +3.9% above its 200-day average, with the 20-day +5.2% away.

How far is AZN.L from its 52-week high?

10.2% below the 52-week high and 41.3% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.